Phcog.Net logo
Submit

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Pharmacognosy ReviewsNOW IN
    Review

    Thymoquinone: A Potential Therapy against Cancer Stem Cells

    Farah Rabih Ballout1, Hala Gali-Muhtasib1★★ Corresponding author

    1. 1Department of Biology and Center for Drug Discovery, American University of Beirut, Beirut, LEBANON.

    CORRESPONDENCE

    Hala Gali-Muhtasib

    Department of Biology and Center for Drug Discovery, American University of Beirut, Beirut, LEBANON.

    frb03@mail.aub.edu

    Received: 19-07-2020; Revised: 03-09-2020; Accepted: 07-12-2020.

    Volume 14, Issue 28 · pp. 155–159 · PUBLISHED · DOI: 10.5530/phrev.2020.14.19

    View on Pharmacogn. Rev. original site ↗

    ABSTRACT

    Background:Cancer remains to be a major health problem despite advances in treatment. Chemo- and radiotherapy resistance accounting for cancer recurrence have been recently attributed to a subpopulation of cells within the tumor, namely cancer stem cells (CSCs). Aim:Hence, it is essential to adopt new therapeutic approaches that target these cells. Methods and Results: The black seed extract Thymoquinone (TQ) has shown promising anti-cancer effects on various cancer types. Here, we provide an overview of TQ’s potential in targeting CSCs with emphasis on its mechanism of action and shed light on its development as a future drug for cancer therapy. Conclusion:TQ showed potency against CSCs either alone or in combination with chemotherapeutic agents.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Ballout, F. R., & Gali-Muhtasib, H. (). Thymoquinone: A Potential Therapy against Cancer Stem Cells. Pharmacognosy Reviews, 14(28), 155–159. https://doi.org/10.5530/phrev.2020.14.19